Doyle Mittie bought AVTX

March 16, 2026 · Form 4 insider transaction

Doyle Mittie bought 19,500 shares of Avalo Therapeutics, Inc. at $12.65 per share, a transaction worth $246.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.